Alfonso Reimúndez

Alfonso Reimúndez

Auto-generated profile, based on publicly available information

Alfonso Reimúndez

Centre for Research in Molecular Medicine and Chronic Diseases. University of Santiago de Compostela. Spain

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2018 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
ARAlfonso Reimúndez
Alfonso Reimúndez
CFCarlos Fernández-Peña
Carlos Fernández-Peña
GGGuillermo García
Guillermo García
RFRubén Fernández
Rubén Fernández
POPurificación Ordás
Purificación Ordás
RSRosa Señarís
Rosa Señarís
The coupling of energy homeostasis to thermoregulation is essential to maintain homeothermy in changing external environments. We studied the role of the cold thermoreceptor TRPM8 in this interplay in mice of both sexes. We demonstrate that TRPM8 is required for a precise thermoregulation in response to cold, in fed and fasting.Trpm8−/−mice exhibited a fall of 0.7°C in core body temperature when housed at cold temperatures, and a deep hypothermia (<30°C) during food deprivation. In both situations, TRPM8 deficiency induced an increase in tail heat loss. This, together with the presence of TRPM8-sensory fibers innervating the main tail vessels, unveils a major role of this ion channel in tail vasomotor regulation. Finally, TRPM8 deficiency had a remarkable impact on energy balance.Trpm8−/−mice raised at mild cold temperatures developed late-onset obesity and metabolic dysfunction, with daytime hyperphagia and reduction of fat oxidation as plausible causal factors. In conclusion, TRPM8 fine-tunes eating behavior and fuel utilization during thermoregulatory adjustments to mild cold. Persistent imbalances in these responses result in obesity.SIGNIFICANCE STATEMENTThe thermosensitive ion channel TRPM8 is required for a precise thermoregulatory response to cold and fasting, playing an important role in tail vasoconstriction, and therefore heat conservation, as well as in the regulation of ingestive behavior and metabolic fuel selection upon cooling. Indeed, TRPM8-deficient mice, housed in a mild cold environment, displayed an increase in tail heat loss and lower core body temperature, associated with the development of late-onset obesity with glucose and lipid metabolic dysfunction. A persistent diurnal hyperphagia and reduced fat oxidation constitute plausible underlying mechanisms in the background of a deficient thermoregulatory adjustment to mild cold ambient temperatures.

3 April 2019 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
POPurificación Ordás
Purificación Ordás
PHPablo Hernández‐Ortego
Pablo Hernández‐Ortego
HRHugo Vara Rivera
Hugo Vara Rivera
CFCarlos Fernández‐Peña
Carlos Fernández‐Peña
ARAlfonso Reimúndez
Alfonso Reimúndez
RSRosa Señarís
Rosa Señarís

26 April 2018 in Pflügers Archiv - European Journal of Physiology
Verified
Journal Article
Closed access
PDF file
RSRosa Señarís
Rosa Señarís
POPurificación Ordás
Purificación Ordás
ARAlfonso Reimúndez
Alfonso Reimúndez
FVFelix Viana
Felix Viana

31 October 2022 in Acta Physiologica
Verified
Journal Article
Open access
ARAlfonso Reimúndez
Alfonso Reimúndez
CFCarlos Fernández‐Peña
Carlos Fernández‐Peña
POPurificación Ordás
Purificación Ordás
PHPablo Hernández‐Ortego
Pablo Hernández‐Ortego
RGRosalía Gallego
Rosalía Gallego
RSRosa Señarís
Rosa Señarís
Aim: Physiological functions in mammals show circadian oscillations, synchronized by daily cycles of light and temperature. Central and peripheral clocks participate in this regulation. Since the ion channel TRPM8 is a critical cold sensor, we investigated its role in circadian function.Methods: We used TRPM8 reporter mouse lines and TRPM8‐deficient mice. mRNA levels were determined by in situ hybridization or RT‐qPCR and protein levels by immunofluorescence. A telemetry system was used to measure core body temperature (Tc).Results: TRPM8 is expressed in the retina, specifically in cholinergic amacrine interneurons and in a subset of melanopsin‐positive ganglion cells which project to the central pacemaker, the suprachiasmatic nucleus (SCN) of the hypothalamus. TRPM8‐positive fibres were also found innervating choroid and ciliary body vasculature, with a putative function in intraocular temperature, as shown in TRPM8‐deficient mice. Interestingly, Trpm8−/− animals displayed increased expression of the clock gene Per2 and vasopressin (AVP) in the SCN, suggesting a regulatory role of TRPM8 on the central oscillator. Since SCN AVP neurons control body temperature, we studied Tc in driven and free‐running conditions. TRPM8‐deficiency increased the amplitude of Tc oscillations and, under dim constant light, induced a greater phase delay and instability of Tc rhythmicity. Finally, TRPM8‐positive fibres innervate peripheral organs, like liver and white adipose tissue. Notably, Trpm8−/− mice displayed a dysregulated expression of Per2 mRNA in these metabolic tissues.Conclusion: Our findings support a function of TRPM8 as a temperature sensor involved in the regulation of central and peripheral clocks and the circadian control of Tc.

24 June 2026 in bioRxiv
Verified
Preprint
Open access
VGV. González-Alvarez
V. González-Alvarez
SCS. Caamaño
S. Caamaño
ARA. Reimúndez
A. Reimúndez
JCJ. Cañas-Martín
J. Cañas-Martín
ACA. Capelo-Diz
A. Capelo-Diz
RSR. Señarís
R. Señarís
Background: Cancer-associated cachexia is characterized by progressive loss of skeletal muscle and adipose tissue driven by systemic inflammation and metabolic dysregulation. AMP-activated protein kinase (AMPK) is a central regulator of energy homeostasis, but its role in cachexia and its therapeutic potential remains incompletely defined. We investigated AMPK signaling during cachexia and whether pharmacological AMPK activation alone or combined with ghrelin could ameliorate disease manifestations. Methods: Cachexia was induced in male C57BL/6 mice by Lewis lung carcinoma (LLC) implantation. Additional models included fibrosarcoma (CHX and MN/MCA1) and chronic lymphocytic choriomeningitis virus (LCMV) infection. AMPK was activated using AICAR and BC1618 (AB), alone or combined with ghrelin (AB+G). Metabolic, inflammatory, and functional outcomes were assessed in hypothalamus, skeletal muscle, adipose tissue, and serum. Results: LLC-bearing mice developed cachexia characterized by reduced body weight, lean and fat mass, hypophagia, and elevated circulating IL-6 and corticosterone. Cachectic LLC mice displayed increased Il6 and Il1β expression in hypothalamus, skeletal muscle, and white adipose tissue (WAT). Furthermore, AMPK activation failed to increase in hypothalamus or peripheral tissues despite profound energy deficit. A similar defect in AMPK responsiveness was observed in CHX and LCMV models, indicating a conserved feature of cachexia. AB treatment in LLC mice reduced circulating IL-6 and corticosterone levels and decreased skeletal muscle atrogene expression and IL-6/STAT3 signaling, partially preserving muscle mass, fiber size, and grip strength. However, food intake remained low, and WAT was largely unresponsive, maintaining elevated Il6 expression and tissue loss. Ghrelin alone increased food intake in LLC mice but did not ameliorate the cachectic phenotype. In contrast, AB+G restored food intake and prevented loss of lean and fat mass. LLC AB+G mice exhibited reduced hypothalamic Il6 and serotonin transporter ( Slc6a4 ) expression, normalized adipocyte morphology and serum leptin levels, decreased adipose Il6 and Atgl expression and reduced WAT sympathetic innervation. AB+G further lowered circulating corticosterone levels, and provided greater protection against muscle wasting, with increased Pgc1α expression and improved muscle function. Neither intervention affected tumor growth or tumor inflammatory gene expression. Conclusions: Cancer cachexia is associated with a central and peripheral failure to appropriately activate AMPK signaling in response to the energetic stress imposed by cachexia. Combined AMPK activation and ghrelin administration exerted complementary effects on energy homeostasis, inflammation, and tissue wasting, resulting in greater protection against cachexia than either intervention alone. These findings support combined AMPK-ghrelin targeting as a promising therapeutic strategy for cancer cachexia.